Liposomes in cosmeceutics

Expert Opinion on Drug Delivery

Volumn 9, Issue 4, 2012, Pages 443-455

  Rahimpour, Yahya ^a   Hamishehkar, Hamed ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cosmeceuticals; Dermatology; Drug carrier; Liposomes; Topical delivery

Indexed keywords

4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; 4 N BUTYLRESORCINOL; ALOE VERA EXTRACT; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBYL PALMITATE; BENZOYL PEROXIDE; BETAMETHASONE DIPROPIONATE; CLINDAMYCIN; COSMETIC; CYCLOSPORIN A; CYPROTERONE ACETATE; DITHRANOL; EPIGALLOCATECHIN GALLATE; FINASTERIDE; GAMMA ORYZANOL; KHELLIN; LAURIC ACID; LIPOSOME; MELATONIN; METHOTREXATE; MINOXIDIL; POVIDONE IODINE; RESORCINOL DERIVATIVE; RESVERATROL; RETINOIC ACID; TAMOXIFEN; UBIDECARENONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSOLIC ACID;

ABSENCE OF SIDE EFFECTS; ACNE; ALOPECIA; ALOPECIA AREATA; ATOPIC DERMATITIS; BIOCOMPATIBILITY; BIODEGRADABILITY; CHLOASMA; CUTANEOUS PARAMETERS; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; DRUG TOLERABILITY; EPIDERMIS; ERYTHEMA; HIRSUTISM; HUMAN; HYPERPIGMENTATION; NONHUMAN; PHOTOAGING; PROPIONIBACTERIUM ACNES; PSORIASIS; RADIATION PROTECTION; REVIEW; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT INDICATION; TREATMENT RESPONSE; ULTRAVIOLET RADIATION; VITILIGO; WOUND;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, TOPICAL; ANTIOXIDANTS; CHEMISTRY, PHARMACEUTICAL; COSMETICS; DERMATOLOGIC AGENTS; DERMIS; EPIDERMIS; HUMANS; LIPOSOMES; PROTECTIVE AGENTS; SKIN; SKIN ABSORPTION; SKIN AGING; SKIN DISEASES; WOUND HEALING;

EID: 84858811433     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2012.666968     Document Type: Review

References (108)

1. Bhalekar MR, Pokharkar V, Madgulkar A, et al. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS PharmSciTech 2009;10(1):289-96
2. Souto EB, Muller RH. Lipid nanoparticles: Effect on bioavailability and pharmacokinetic changes. Handb Exp Pharmacol 2010;197(2):115-41
3. Barichello JM, Yamakawa N, Kisyuku M, et al. Combined effect of liposomalization and addition of glycerol on the transdermal delivery of isosorbide 5-nitrate in rat skin. Int J Pharm 2008;357(1):199-205
4. Verma P, Ram A. Effect of different penetration enhancers on skin permeation of drug using ethosomal carrier systems. J Curr Pharm Res 2011;5(1):42-4
5. Bouwstra J, Honeywell-Nguyen P. Skin structure and mode of action of vesicles. Adv Drug Deliv Rev 2002;54:S41-55
6. Higaki K, Nakayama K, Suyama T, et al. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin. Int J Pharm 2005;288(2):227-33
7. Ghafourian T, Zandasrar P, Hamishekar H, et al. The effect of penetration enhancers on drug delivery through skin: A QSAR study. J Controlled Release 2004;99 (1):113-25
8. Souto EB, Muller RH, Alemieda AJ. Topical delivery of oily actives using solid lipid particles. Pharmaceut Tech Eur 2007;19:12 An excellent paper introducing lipidic nano- And microparticles and their application on topical delivery.
9. Kaur IP, Kapila M, Agrawal R. Role of novel delivery systems in developing topical antioxidants as therapeutics to combat photoageing. Ageing Res Rev 2007;6(4):271-88 A great review on the role of carriers in topical delivery of antioxidants.
10. Jaspart S, Piel G, Delattre L, et al. Solid lipid microparticles: Formulation, preparation, characterisation, drug release and applications. Expert Opin Drug Deliv 2005;2(1):75-87
11. Yang D, Pornpattananangkul D, Nakatsuji T, et al. The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes. Biomaterials 2009;30(30):6035-40
12. Abraham W, Wertz PW, Downing DT. Fusion patterns of liposomes formed from stratum corneum lipids. J Invest Dermatol 1988; 90(3):259-62
13. De Leeuw J, De Vijlder H, Bjerring P, et al. Liposomes in dermatology today. J Eur Acad Dermatol Venereol 2009;23(5):505-16 A general review about the role of liposomes in transdermal delivery.
14. Mezei M, Gulasekharam V. Liposomes-A selective drug delivery system for the topical route of administration. Lotion dosage form. Life Sci 1980;26(18):1473-7
15. Carafa M, Marianecci C, Di Marzio L, et al. A new vesicle-loaded hydrogel system suitable for topical applications: Preparation and characterization. J Pharm Pharm Sci 2011; 14(3):336-46
16. Nounou MM, El-Khordagui LK, Khalafallah NA, et al. Liposomal formulation for dermal and transdermal drug delivery: Past, present and future. Recent Pat Drug Deliv Formul 2008;2(1):9-18 A good paper discussing various types of liposomal preparations for topical drug delivery.
17. Betz G, Aeppli A, Menshutina N, et al. In vivo comparison of various liposome formulations for cosmetic application. Int J Pharm 2005;296(1-2):44-54
18. Teichmann A, Ossadnik M, Richter H, et al. Semiquantitative determination of the penetration of a fluorescent hydrogel formulation into the hair follicle with and without follicular closure by microparticles by means of differential stripping. Skin Pharmacol Physiol 2006;19(2):101-5
19. Niemiec SM, Ramachandran C, Weiner N. Influence of nonionic liposomal composition on topical delivery of peptide drugs into pilosebaceous units: An in vivo study using the hamster ear model. Pharm Res 1995;12(8):1184-8
20. Egbaria K, Weiner N. Liposomes as a topical drug delivery system. Adv Drug Deliv Rev 1990;5(3):287-300
21. Cevc G. Drug delivery across the skin. Expert Opin Investig Drugs 1997;6(12):1887-937
22. Alsarra IA, Bosela AA, Ahmed SM, et al. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm 2005;59(3):485-90
23. Taglietti M, Hawkins C, Rao J. Novel topical drug delivery systems and their potential use in acne vulgaris. Skin Therapy Lett 2008;13(5):6-8
24. Higaki S. Lipase inhibitors for the treatment of acne. J Mol Catalysis B Enzym 2003;22(5-6):377-84
25. Skalko N, Cajkovac M, Jalsenjak I. Liposomes with clindamycin hydrochloride in the therapy of acne vulgaris. Int J Pharm 1992;85(1-3):97-101
26. Patel V, Misra A, Marfatia Y. Preparation and comparative clinical evaluation of liposomal gel of benzoyl peroxide for acne. Drug Dev Ind Pharm 2001;27(8):863-70
27. Sinico C, Manconi M, Peppi M, et al. Liposomes as carriers for dermal delivery of tretinoin: In vitro evaluation of drug permeation and vesicle-skin interaction. J Control Release 2005;103(1):123-36
28. Kitagawa S, Kasamaki M. Enhanced delivery of retinoic acid to skin by cationic liposomes. Chem Pharm Bull (Tokyo) 2006;54(2):242-4
29. Fresno Contreras M, Jimenez Soriano M, Ramirez Dieguez A. In vitro percutaneous absorption of all-trans retinoic acid applied in free form or encapsulated in stratum corneum lipid liposomes. Int J Pharm 2005;297(1-2):134-45
30. Bhalerao S, Raje Harshal A. Preparation, optimization, characterization, and stability studies of salicylic acid liposomes. Drug Dev Ind Pharm 2003;29(4):451-67
31. Tan G, Xu P, Lawson LB, et al. Hydration effects on skin microstructure as probed by high-resolution cryoscanning electron microscopy and mechanistic implications to enhanced transcutaneous delivery of biomacromolecules. J Pharm Sci 2010;99(2):730-40
32. Wissing SA, Muller RH. The influence of solid lipid nanoparticles on skin hydration and viscoelasticity-in vivo study. Eur J Pharm Biopharm 2003;56(1):67-72
33. Machado M, Bronze M, Ribeiro H. New cosmetic emulsions for dry skin. J Cosmet Dermatol 2007;6(4):239-42
34. Wissing SA, Muller RH. The influence of the crystallinity of lipid nanoparticles on their occlusive properties. Int J Pharm 2002;242(1-2):377-9
35. Leite e Silva VR, Schulman MA, Ferelli C, et al. Hydrating effects of moisturizer active compounds incorporated into hydrogels: In vivo assessment and comparison between devices. J Cosmet Dermatol 2009;8(1):32-9
36. Mahdavi H, Kermani Z, Faghihi G, et al. Preparation and evaluation of cosmetic patches containing lactic and glycolic acids. Indian Journal of Dermatology, Venereology, and Leprology 2006;72 (6):432
37. Perugini P, Genta I, Pavanetto F, et al. Study on glycolic acid delivery by liposomes and microspheres. Int J Pharm 2000;196(1):51-61
38. Schmid M, Korting H. Liposomes for atopic dry skin: The rationale for a promising approach. J Mol Med 1993;71(8):649-53
39. Rigopoulos D, Gregoriou S, Katsambas A. Hyperpigmentation and melasma. J Cosmet Dermatol 2007;6(3):195-202
40. Huh SY, Shin JW, Na JI, et al. Efficacy and safety of liposome-encapsulated 4-n-butylresorcinol 0.1% cream for the treatment of melasma: A randomized controlled split-face trial. J Dermatol 2010;37(4):311-15
41. Shigeta Y, Imanaka H, Ando H, et al. Skin whitening effect of linoleic acid is enhanced by liposomal formulations. Biol Pharm Bull 2004;27(4):591-4
42. Shigeta Y, Imanaka H, Yonezawa S, et al. Suppressed permeation of linoleic acid in a liposomal formulation through reconstructed skin tissue. Biol Pharm Bull 2004;27(6):879-82
43. Celia C, Cilurzo F, Trapasso E, et al. Ethosomes® and transfersomes® containing linoleic acid: Physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders. Biomed Microdevices 2011; Epub ahead of print: DOI 10.1007/s10544-011-9590-y
44. Nogueira LS, Zancanaro PC, Azambuja RD. Vitiligo and emotions. An Bras Dermatol 2009;84(1):41-5
45. De Leeuw J, Assen Y, Van Der Beek N, et al. Treatment of vitiligo with khellin liposomes, ultraviolet light and blister roof transplantation. J Eur Acad Dermatol Venereol 2011;25(1):74-81
46. Ciotti SN, Weiner N. Follicular liposomal delivery systems. J Liposome Res 2002;12(1-2):143-8
47. Han I, Kim M, Kim J. Enhanced transfollicular delivery of adriamycin with a liposome and iontophoresis. Exp Dermatol 2004;13(2):86-92
48. Jung S, Otberg N, Thiede G, et al. Innovative liposomes as a transfollicular drug delivery system: Penetration into porcine hair follicles. J Invest Dermatol 2006;126(8):1728-32
49. Messenger A, Rundegren J. Minoxidil: Mechanisms of action on hair growth. Br J Dermatol 2004;150(2):186-94
50. Mura S, Pirot F, Manconi M, et al. Liposomes and niosomes as potential carriers for dermal delivery of minoxidil. J Drug Target 2007;15(2):101-8
51. Jain B, Singh B, Katare OP, et al. Development and characterization of minoxidil-loaded liposomal system for delivery to pilosebaceous units. J Liposome Res 2010;20(2):105-14
52. Javadzadeh Y, Shokri J, Hallaj-Nezhadi S, et al. Enhancement of percutaneous absorption of Finasteride by cosolvents, cosurfactant and surfactants. Pharm Dev Technol 2010; 15(6):619-25
53. Tabbakhian M, Tavakoli N, Jaafari MR, et al. Enhancement of follicular delivery of finasteride by liposomes and niosomes:: 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm 2006;323(1-2):1-10
54. Im Lee S, Sriraman N, Baskaran R, et al. Original article: Effect of charge carrier lipid on skin penetration, retention, and hair growth of topically applied finasteride-containing liposomes. Biomol Ther 2011;19(2):231-6
55. Verma D, Verma S, McElwee K, et al. Treatment of alopecia areata in the DEBR model using Cyclosporin A lipid vesicles. EJD 2004;14(5):332-8
56. Meidan VM, Bonner MC, Michniak BB. Transfollicular drug delivery-is it a reality? Int J Pharm 2005; 306(1-2):1-14
57. Tschan T, Steffen H, Supersaxo A. Sebaceous-gland deposition of isotretinoin after topical application: An in vitro study using human facial skin. Skin Pharmacol Physiol 1997;10(3):126-34
58. Nikolic S, Keck CM, Anselmi C, et al. Skin photoprotection improvement: Synergistic interaction between lipid nanoparticles and organic UV filters. Int J Pharm 2011;414(1-2):276-84
59. Ziegler A, Jonason AS, Leffellt DJ, et al. Sunburn and p53 in the onset of skin cancer. Nature 1994;372(6508):773-6
60. Schneider SB. Global cosmetic regulations? A long way to go. Global Regul Issues Cosmet Industry 2009;2:189
61. Golmohammadzadeh S, Jaafarixx M, Khalili N. Evaluation of liposomal and conventional formulations of octyl methoxycinnamate on human percutaneous absorption using the stripping method. J Cosmet Sci 2008;59(5):385
62. Allemann IB, Baumann L. Antioxidants used in skin care formulations. Skin Therapy Lett 2008;13(7):5-9
63. Rivers J. The role of cosmeceuticals in antiaging therapy. Skin Therapy Lett 2008;13(8):5-9
64. Rozman B, Zvonar A, Falson F, et al. Temperature-sensitive microemulsion gel: An effective topical delivery system for simultaneous delivery of vitamins C and E. AAPS PharmSciTech 2009;10(1):54-61
65. Jentzsch A, Streicher H, Engelhart K. The synergistic antioxidative effect of ascorbyl 2-phosphate and alpha-tocopheryl acetate. Cosmet Toilet 2001;116(6):55-64
66. Foco A, Gasperlin M, Kristl J. Investigation of liposomes as carriers of sodium ascorbyl phosphate for cutaneous photoprotection. Int J Pharm 2005;291(1-2):21-9
67. Lee S, Lee J, Choi YW. Skin permeation enhancement of ascorbyl palmitate by liposomal hydrogel (lipogel) formulation and electrical assistance. Biol Pharm Bull 2007;30(2):393-6
68. Dubey V, Mishra D, Jain N. Melatonin loaded ethanolic liposomes: Physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm 2007;67(2):398-405
69. Takahashi M, Kitamoto D, Asikin Y, et al. Liposomes encapsulating aloe vera leaf gel extract significantly enhance proliferation and collagen synthesis in human skin cell lines. J Oleo Sci 2009;58(12):643-50
70. Vayalil PK, Mittal A, Hara Y, et al. Green tea polyphenols prevent ultraviolet light-induced oxidative damage and matrix metalloproteinases expression in mouse skin. J Invest Dermatol 2004;122(6):1480-7
71. Fang JY, Hwang TL, Huang YL, et al. Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int J Pharm 2006;310(1-2):131-8
72. Yarosh DB, Both D, Brown D. Liposomal ursolic acid (merotaine) increases ceramides and collagen in human skin. Horm Res Paediatr 2000;54(5-6):318-21
73. Martelli L, Berardesca E, Martelli M. Topical formulation of a new plant extract complex with refirming properties. Clinical and non-invasive evaluation in a double-blind trial. Int J Cosmet Sci 2000;22(3):201-6
74. Caddeo C, Teskac K, Sinico C, et al. Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. Int J Pharm 2008;363(1-2):183-91
75. Yue Y, Zhou H, Liu G, et al. The advantages of a novel CoQ10 delivery system in skin photo-protection. Int J Pharm 2010;392(1):57-63
76. Tanino Y, Budiyanto A, Ueda M, et al. Decrease of antioxidants and the formation of oxidized diacylglycerol in mouse skin caused by UV irradiation. J Dermatol Sci Suppl 2005; 1(2):S21-S8
77. Lee WC, Tsai TH. Preparation and characterization of liposomal coenzyme Q10 for in vivo topical application. Int J Pharm 2010;395(1-2):78-83
78. Cicero A, Gaddi A. Rice bran oil and gamma-Oryzanol in the treatment of hyperlipoproteinaemias and other conditions. Phytother Res 2001;15(4):277-89
79. Akihisa T, Yasukawa K, Yamaura M, et al. Triterpene alcohol and sterol ferulates from rice bran and their anti-inflammatory effects. J Agric Food Chem 2000;48(6):2313-19
80. Xu Z, Hua N, Godber JS. Antioxidant activity of tocopherols, tocotrienols, and gamma-oryzanol components from rice bran against cholesterol oxidation accelerated by 2, 2'-Azobis (2-methylpropionamidine) dihydrochloride. J Agric Food Chem 2001;49(4):2077-81
81. Viriyaroj A, Ngawhirunpat T, Sukma M, et al. Physicochemical properties and antioxidant activity of gamma-oryzanol-loaded liposome formulations for topical use. Pharm Dev Technol 2009; 14(6):665-71
82. Padamwar MN, Pokharkar VB. Development of vitamin loaded topical liposomal formulation using factorial design approach: Drug deposition and stability. Int J Pharm 2006;320(1-2):37-44
83. Dubey V, Mishra D, Dutta T, et al. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release 2007;123(2):148-54
84. Su YH, Fang JY. Drug delivery and formulations for the topical treatment of psoriasis. Expert Opin Drug Deliv 2008;5(2):235-49
85. A comprehensive review about psoriasis and different strategies for its treatment. 85. Javadzadeh Y, Hamishehkar H. Enhancing percutaneous delivery of methotrexate using different types of surfactants Colloids Surf B Biointerfaces 2011 82 2 422-6
86. Ali MFM, Salah M, Rafea M, et al. Liposomal methotrexate hydrogel for treatment of localized psoriasis: Preparation, characterization and laser targeting. Med Sci Monit 2008;14(12):166-74
87. Trotta M, Peira E, Carlotti ME, et al. Deformable liposomes for dermal administration of methotrexate. Int J Pharm 2004;270(1-2):119-25
88. Agarwal R, Katare O, Vyas S. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 2001;228(1-2):43-52
89. Saraswat A, Agarwal R, Katare OP, et al. A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis. J Dermatolog Treat 2007;18(1):40-5
90. Erdogan M, Wright J, McAlister V. Liposomal tacrolimus lotion as a novel topical agent for treatment of immune-mediated skin disorders: Experimental studies in a murine model. Br J Dermatol 2002;146(6):964-7
91. Shaw JC. Antiandrogen therapy in dermatology. Int J Dermatol 1996;35(11):770-8
92. Hammerstein J, Meckies J, Leo-Rossberg I, et al. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism. J Steroid Biochem 1975;6(6):827-36
93. Valenta C, Janisch M. Permeation of cyproterone acetate through pig skin from different vehicles with phospholipids. Int J Pharm 2003;258(1-2):133-9
94. Mohammadi-Samani S, Montaseri H, Jamshidnejad M. Preparation and evaluation of cyproterone acetate liposome for topical drug delivery. Iran J Pharm Sci 2009;5(4):199-204
95. Bhatia A, Singh B, Amarji B, et al. Tamoxifen-loaded liposomal topical formulation arrests hair growth in mice. Br J Dermatol 2010;163(2):412-15
96. De Benedetto A, Agnihothri R, McGirt LY, et al. Atopic dermatitis: A. disease caused by innate immune defects & quest. J Invest Dermatol 2009;129(1):14-30
97. Korting H, Zienicke H, Schafer-Korting M, et al. Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris. Eur J Clin Pharmacol 1990;39(4):349-51
98. Trotta M, Peira E, Debernardi F, et al. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm 2002;241(2):319-27
99. Jung SH, Cho YS, Jun SS, et al. Topical application of liposomal cobalamin hydrogel for atopic dermatitis therapy. Pharmazie 2011;66(6):430-5
100. Judith R, Nithya M, Rose C, et al. Application of a PDGF-containing novel gel for cutaneous wound healing. Life Sci 2010;87(1-2):1-8
101. Sukkma A, Ahoaan R. Effect of povidone-iodine liposome hydrogel on colonic anastomosis. Eur Surg Res 2005;37:242-5
102. Vogt PM, Hauser J, Rossbach O, et al. Polyvinyl pyrrolidone-iodine liposome hydrogel improves epithelialization by combining moisture and antisepis. A new concept in wound therapy. Wound Repair Regen 2001;9(2):116-22
103. Beukelman CJ, van den Berg AJ, Hoekstra MJ, et al. Anti-inflammatory properties of a liposomal hydrogel with povidone-iodine (Repithel) for wound healing in vitro. Burns 2008;34(6):845-55
104. Rawlings A. Cellulite and its treatment. Int J Cosmet Sci 2006;28(3):175-90
105. Khazaeli P, Pardakhty A, Shoorabi H. Caffeine-loaded niosomes: Characterization and in vitro release studies. Drug Deliv 2007;14(7):447-52
106. Tholon L, Neliat G, Chesne C, et al. An in vitro, ex vivo, and in vivo demonstration of the lipolytic effect of slimming liposomes: An unexpected alpha2-Adrenergic antagonism. J Cosmet sci 2002;53:209-18
107. Maibach H, Choi M. Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol Physiol 2005;18:209-19 A good review article summarizes relation of the topical/transdermal drug delivery efficiency with composition, size and type of the vesicular system such as liposomes, niosomes, proliposomes and proniosomes.
108. Gonzalez-Rodriguez M, Rabasco A. Charged liposomes as carriers to enhance the permeation through the skin. Expert Opin Drug Deliv 2011;8(7):1-15 An excellent paper discusses the effect of liposomes charged on transdermal drug delivery.